Table4_卵巢癌铁死亡相关生物标志物特征整合分析以改善诊断与预后预测

卵巢癌铁死亡相关生物标志物整合分析XLS表,涵盖诊断/预后特征、风险评分及免疫治疗反应。

NIAID Data Ecosystem
浏览 14
表格ovarian cancerferroptosis-related genesdiagnosisprognosisimmunotherapychemotherapy
Table4_Integrated Analysis of Ferroptosis-Related Biomarker Signatures to Improve the Diagnosis and Prognosis Prediction of Ovarian Cancer.XLS

基本信息

模态
表格
大小
0.000241664 GB
许可
CC BY 4.0
创建/更新时间
2026-10-10
版本
v1

资源简介

Table4_卵巢癌铁死亡相关生物标志物特征整合分析以改善诊断与预后预测

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 241.66 KB,主题涵盖 ovarian cancer、ferroptosis-related genes、diagnosis、prognosis、immunotherapy,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Table4_Integrated Analysis of Ferroptosis-Related Biomarker Signatures to Improve the Diagnosis and Prognosis Prediction of Ovarian Cancer.XLS》。配套论文《Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo》发表于 Journal of Obstetrics and Gynaecology Research(2021),DOI:10.1111/jog.14779。源站首次发布:2022-01-05。

【数据内容】

源站原始描述:Ovarian cancer remains the most lethal gynecological malignancy. Ferroptosis, a specialized form of iron-dependent, nonapoptotic cell death, plays a crucial role in various cancers. However, the contribution of ferroptosis to ovarian cancer is poorly understood. Here, we characterized the diagnostic, prognostic, and therapeutic value of ferroptosis-related genes in ovarian cancer by analyzing transcriptomic data from The Cancer Genome Atlas and Gene Expression Omnibus databases. A reliable 10-ge…

【数据结构与技术规格】

文件数 1 个,合计 241.66 KB。Table4_Integrated Analysis of Ferroptosis-Related Biomarker Signatures to Improve the Diagnosis and Prognosis Prediction of Ovarian Cancer.XLS:application/vnd.ms-excel,241.66 KB。数据集 DOI:10.3389/fcell.2021.807862.s006。

【主题与分类】

源站学科分类:Cell Biology、Cell Development, Proliferation and Death、Cell Metabolism、Cell Neurochemistry、Cellular Interactions (incl. Adhesion, Matrix, Cell Wall)、Marine Biology。主题标签:ovarian cancer、ferroptosis-related genes、diagnosis、prognosis、immunotherapy、chemotherapy。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://frontiersin.figshare.com/articles/dataset/Table4_Integrated_Analysis_of_Ferroptosis-Related_Biomarker_Signatures_to_Improve_the_Diagnosis_and_Prognosis_Prediction_of_Ovarian_Cancer_XLS/17869424

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Wang, Huan; Cheng, Qi; Chang, Kaikai; Bao, Lingjie; Yi, Xiaofang (2022). Table4_Integrated Analysis of Ferroptosis-Related Biomarker Signatures to Improve the Diagnosis and Prognosis Prediction of Ovarian Cancer.XLS. Frontiers. Dataset

【使用注意】

· 源站最后修改于 2023-06-05,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "Table4_Integrated Analysis of Ferroptosis-Related Biomarker Signatures to Improve the Diagnosis and Prognosis Prediction of Ovarian Cancer.XLS" "https://ndownloader.figshare.com/files/32582930"

文件清单

  • Table4_Integrated Analysis of Ferroptosis-Related Biomarker Signatures to Improve the Diagnosis and Prognosis Prediction of Ovarian Cancer.XLS(241.66 KB)

文件总体积 241.66 KB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Ovarian cancer remains the most lethal gynecological malignancy. Ferroptosis, a specialized form of iron-dependent, nonapoptotic cell death, plays a crucial role in various cancers. However, the contribution of ferroptosis to ovarian cancer is poorly understood. Here, we characterized the diagnostic, prognostic, and therapeutic value of ferroptosis-related genes in ovarian cancer by analyzing transcriptomic data from The Cancer Genome Atlas and Gene Expression Omnibus databases. A reliable 10-gene ferroptosis signature (HIC1, ACSF2, MUC1, etc.) for the diagnosis of ovarian cancer was identified. Notably, we constructed and validated a novel prognostic signature including three FRGs: HIC1, LPCAT3, and DUOX1. We also further developed a risk score model based on these three genes which divided ovarian cancer patients into two risk groups. Functional analysis revealed that immune response and immune-related pathways were enriched in the high-risk group. Meanwhile, the tumor microenvironment was distinct between the two groups, with more M2 Macrophage infiltration and higher expression of key immune checkpoint molecules in the high-risk group than in the other group. Low-risk patients exhibited more favorable immunotherapy and chemotherapy responses. We conclude that crosstalk between ferroptosis and immunity may contribute to the worse prognosis of patients in the high-risk group. In particular, HIC1 showed both diagnostic and prognostic value in ovarian cancer. In vitro experiments demonstrated that inhibition of HIC1 improved drug sensitivity of chemotherapy and immunotherapy agents by inducing ferroptosis. Our findings provide new insights into the potential role of FRGs in the early detection, prognostic prediction, and individualized treatment decision-making for ovarian cancer patients.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fcell.2021.807862.s006(source: https://frontiersin.figshare.com/articles/dataset/Table4_Integrated_Analysis_of_Ferroptosis-Related_Biomarker_Signatures_to_Improve_the_Diagnosis_and_Prognosis_Prediction_of_Ovarian_Cancer_XLS/17869424)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案